Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-05-000413
Filing Date
2005-01-18
Accepted
2005-01-18 15:15:17
Documents
3
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K e69543e10vkza.txt 10-K/A 5792
2 CERTIFICATION e69543exv31w1.txt EX-31.1 931
3 CERTIFICATION e69543exv31w2.txt EX-31.2 927
  Complete submission text file 0000950123-05-000413.txt   9567
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 10-K/A | Act: 34 | File No.: 000-15190 | Film No.: 05533576
SIC: 2835 In Vitro & In Vivo Diagnostic Substances